Patients Come First
Recent News About Patients Come First
-
Executive director of Patients Come First: 'The biggest flaw in the 340B program is that the discounts don’t have to go to the beneficiaries'
Concerns are mounting over the federal 340B drug pricing program, which was intended to provide affordable medications to low-income patients, as evidence suggests that some large health systems are using the program’s benefits to generate profits. The 340B program, established to supply safety-net hospitals with deeply discounted drugs, is now the second-largest federal prescription drug initiative, surpassing Medicare Parts B and D in scale.
-
Patients Come First Director: Government price controls lead to 'loss of innovation in the marketplace,' patients suffering
Jeanette Hoffman, the executive director of advocacy organization Patients Come First (PCF), said government interference with prices in the drug industry leads to a "loss of innovation in the marketplace," negatively impacting patients and their treatment options.